The Purina® Pro Plan® Breed Update newsletters cover the latest research advances in canine health and genetics for specific dog breeds, plus there is a general dog newsletter. Explore our archive of articles or use the filters to access specific information.
Most Rottweiler owners will agree no canine cancer is as scary as hemangiosarcoma (HSA). Challenging to diagnose and equally difficult to treat, HSA often renders a one-punch knockout when a tumor ruptures causing dogs to bleed to death internally.
An outgoing, friendly breed, the Labrador Retriever is often described as an ideal companion. Natural sporting dogs, Labradors glow with enthusiasm whether training for retrieving water blinds or a bumper thrown from a dock.
Osteosarcoma, or bone cancer, is a tough, complicated malignancy. No one knows exactly what causes osteosarcoma; however, large and giant breeds are considered to be at higher risk due to their size and weight.
As sentinels of breed health, parent clubs turn to dog breeders and owners to gather information. Their ability to understand the changing demographics of disease incidence is pivotal to breed improvement and sometimes even breed survival.
Advances treating canine diseases, such as cancer, often come from innovative studies patterned after human medicine. New therapies using checkpoint molecules and personalized medicine for canine mast cell tumor provide a promising future.
Lafora disease in Miniature Wirehaired Dachshunds is a late-onset progressive myoclonic epilepsy that occurs around 7 years of age. The disease occurred in dogs in the U.K. for decades before the autosomal recessive gene mutation was discovered
Boxers are among the breeds with an increased risk for mast cell tumor, the most common skin cancer in dogs. Mast cells are an important part of the immune system, but when they replicate out of control, they form an aggressive cancer.